Mouse Models of Breast Cancer Share Amplification and Deletion Events with Human Breast Cancer
- 26 January 2017
- journal article
- research article
- Published by Springer Nature in Journal of Mammary Gland Biology and Neoplasia
- Vol. 22 (1) , 71-84
Abstract
Breast tumor heterogeneity has been well documented through the use of multiplatform –omic studies in human tumors. However, there is no integrative database to capture the heterogeneity within mouse models of breast cancer. This project identifies genomic copy number alterations (CNAs) in 600 tumors across 27 major mouse models of breast cancer through the application of a predictive algorithm to publicly available gene expression data. It was found that despite the presence of strong oncogenic drivers in most mouse models, CNAs are extremely common but heterogeneous both between models and within models. Many mouse CNA events are largely conserved in human tumors and in the mouse we show that they are associated with secondary tumor characteristics such as tumor histology, metastasis, as well as enhanced oncogenic signaling. These data serve as an important resource in guiding investigators when choosing a mouse model to understand the gene copy number changes relevant to human breast cancer.Keywords
Funding Information
- National Cancer Institute (R01CA160514, F99CA212221)
This publication has 53 references indexed in Scilit:
- Comprehensive molecular portraits of human breast tumoursNature, 2012
- The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroupsNature, 2012
- Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomesNature Medicine, 2011
- Comparative oncogenomics identifies breast tumors enriched in functional tumor-initiating cellsProceedings of the National Academy of Sciences, 2011
- A pathway-based classification of human breast cancerProceedings of the National Academy of Sciences, 2010
- An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patientsBreast Cancer Research and Treatment, 2009
- Genetic heterogeneity of Myc-induced mammary tumors reflecting diverse phenotypes including metastatic potentialProceedings of the National Academy of Sciences, 2009
- MTDH Activation by 8q22 Genomic Gain Promotes Chemoresistance and Metastasis of Poor-Prognosis Breast CancerCancer Cell, 2009
- A mouse model of basal‐like breast carcinoma with metaplastic elementsThe Journal of Pathology, 2007
- Oncogenic pathway signatures in human cancers as a guide to targeted therapiesNature, 2005